Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
HNDA NDCM NPN SON Small Value Education ISP Tech Funds 
United States  USA  |  Create Portfolios


Processing
Collecting data for YHOO and MRK ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 Yahoo! Inc.  vs   Merck & Co. Inc.
 Compare Fundamentals  
Daily Returns (%)
YHOO   MRK   
 
Given investment horizon of 30 days, Yahoo! Inc is expected to generate 1.54 times more return on investment than Merck. However, Yahoo is 1.54 times more volatile than Merck Co Inc. It trades about 0.34 of its potential returns per unit of risk. Merck Co Inc is currently generating about -0.13 per unit of risk. If you would invest  2,395  in Yahoo! Inc on April 19, 2013 and sell it today you would earn a total of  257.00  from holding Yahoo! Inc or generate 10.73% return on investment over 30 days.

Diversification

Modest diversification
Overlapping area represents amount of risk that can be diversified away by holding Yahoo! Inc. and Merck & Co. Inc. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.2
Parameters
Time Period1 Month [change]
DirectionPositive MRK Moved Up vs YHOO
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between YHOO and MRK with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between YHOO and MRK to your reader
 
Share Correlation between YHOO and MRK 
Find Opportunities
 
Predicted Return Density
 
Returns   
YHOO   MRK   

Yahoo! Inc

 
    
Yahoo
Performance
18
Out Of
100
Over 30
Days
82% of all equities and portfolios perform better than Yahoo! Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Yahoo! Inc are ranked lower than 18 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for Yahoo

Google Inc vs. Yahoo! Inc
Facebook Inc vs. Yahoo! Inc
Baidu Inc vs. Yahoo! Inc
Akamai Technologies Inc vs. Yahoo! Inc
IAC-InterActiveCorp vs. Yahoo! Inc
ValueClick Inc vs. Yahoo! Inc
SouFun Holdings Ltd vs. Yahoo! Inc
Sohu Inc vs. Yahoo! Inc
  

Merck Co Inc

 
    
Merck
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Merck Co Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match ups for Merck

Johnson Johnson vs. Merck Co Inc
Pfizer Inc vs. Merck Co Inc
Novartis AG vs. Merck Co Inc
Sanofi vs. Merck Co Inc
GlaxoSmithKline plc vs. Merck Co Inc
BristolMyers Squibb Company vs. Merck Co Inc
AstraZeneca PLC vs. Merck Co Inc
Eli Lilly and Company vs. Merck Co Inc
Impax Laboratories Inc vs. Merck Co Inc


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium